Calcium 2-aminoethylphosphate
![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
![]() | |
Names | |
---|---|
Preferred IUPAC name
Calcium 2-aminoethyl phosphate | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C2H6CaNO4P | |
Molar mass | 179.13 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Calcium 2-aminoethylphosphate (Ca-AEP or Ca-2AEP) is a compound discovered by the biochemist Erwin Chargaff in 1941.[citation needed] It is the calcium salt of phosphorylethanolamine. It was patented by Hans Alfred Nieper and Franz Kohler.[citation needed]
Terminology and glossary
Calcium 2-amino ethyl phosphoric acid (Ca-AEP or Ca-2AEP) is also called calcium ethylamino-phosphate (calcium EAP), calcium colamine phosphate, calcium 2-aminoethyl ester of phosphoric acid, and calcium 2-amino ethanol phosphate
2-AEP plays a role as a component in the cell membrane and at the same time has the property to form complexes with minerals. This mineral transporter goes into the outer layer of the outer cell membrane where it releases its associated mineral and is itself metabolized with the structure of the cell membrane.[clarification needed][citation needed]
History, treatments, uses, and risks
Ca-AEP was discovered by Erwin Chargaff in 1953.[citation needed]
According to the U.S. National Multiple Sclerosis Society Calcium EAP is often promoted as a cure or therapy for Multiple Sclerosis and many other diseases. However, it states that it is not recommended by its medical advisory board, and also notes that the Food and Drug Administration has classified it as unsafe and unapproved for use.[1]
Calcium 2-AEP is manufactured by numerous nutraceutical companies and is sold online and in health food stores.
References
- ^ "Calcium EAP (Calcium Orotate)" (PDF). National MS Society Information Sourcebook. 2006.
- Articles needing additional references from June 2022
- All articles needing additional references
- Articles with topics of unclear notability from June 2022
- All articles with topics of unclear notability
- Articles needing more viewpoints from June 2022
- Articles with multiple maintenance issues
- Articles without InChI source
- Articles without EBI source
- Articles without KEGG source
- Articles with changed CASNo identifier
- Articles with changed FDA identifier
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Articles with short description
- Short description matches Wikidata
- All articles with unsourced statements
- Articles with unsourced statements from June 2022
- Wikipedia articles needing clarification from February 2009
- All stub articles
- Alternative medicine stubs
- Calcium compounds
- Organophosphates
- Membrane biology
- Multiple sclerosis